We are live on ! Find out more
SLN

Silence Therapeutics
SLN

22 hedge funds and large institutions have $247M invested in Silence Therapeutics in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more capital invested

Capital invested by funds: $39.4M → $247M (+$207M)

214% more funds holding

Funds holding: 7 → 22 (+15)

9.34% more ownership

Funds ownership: 2.18% → 11.52% (+9.3%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
22
Holders Change
+15
Holders Change %
+214.29%
% of All Funds
0.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
6
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LOAMU
Lombard Odier Asset Management (USA)
New York
+$66.5M
2
FM
Frazier Management
Washington
+$20.5M
3
Goldman Sachs
Goldman Sachs
New York
+$17.6M
4
Axa
Axa
France
+$15.3M
5
CCM
Consonance Capital Management
New York
+$13.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$83M +$66.5M +2,874,380 +481%
DTC
2
Deep Track Capital
Connecticut
$22.7M +$22M +950,798 New
FM
3
Frazier Management
Washington
$21.2M +$20.5M +886,173 New
Goldman Sachs
4
Goldman Sachs
New York
$18.2M +$17.6M +760,000 New
CCM
5
Consonance Capital Management
New York
$18.1M +$13.4M +579,466 +324%
Axa
6
Axa
France
$15.8M +$15.3M +661,666 New
BI
7
BVF Inc
California
$15.6M – – –
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$13.1M +$2.44M +105,556 +24%
GPP
9
Great Point Partners
Connecticut
$10.6M +$10.3M +444,443 New
CF
10
Cantor Fitzgerald
New York
$6.08M +$5.89M +254,519 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$5.97M +$5.79M +250,000 New
HSBC Holdings
12
HSBC Holdings
United Kingdom
$4.28M +$4.15M +179,290 New
Morgan Stanley
13
Morgan Stanley
New York
$3.99M +$3.62M +156,239 +1,472%
SG Americas Securities
14
SG Americas Securities
New York
$2.38M +$2.06M +89,143 +702%
UBS Group
15
UBS Group
Switzerland
$1.68M +$1.63M +70,218 New
Citigroup
16
Citigroup
New York
$1.36M +$1.35M +58,333 New
William Blair & Company
17
William Blair & Company
Illinois
$1.34M +$268K +11,582 +26%
BG
18
Bellevue Group
Switzerland
$1.09M +$1.08M +46,666 New
JP Morgan Chase
19
JP Morgan Chase
New York
$157K +$156K +6,730 New
CSS
20
Cubist Systematic Strategies
Connecticut
$4K +$4.26K +184 New
SPIA
21
Steward Partners Investment Advisory
New York
$2K +$2.31K +100 New
TWA
22
TCI Wealth Advisors
Arizona
– +$231 +10 New

SLN Hedge Fund Activity: Q4 2021 in Review

22 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Silence Therapeutics (SLN) for Q4 2021, worth a combined $247M — up 527% from $39.4M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new SLN positions and 0 closed out — a net gain of 15 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Lombard Odier Asset Management (USA), adding an estimated $66.5M.

  • 22 institutional investors held Silence Therapeutics (SLN) as of Q4 2021, up from 7 in Q3 2021.
  • Funds reported $247M of Silence Therapeutics stock for Q4 2021, up 527% quarter-over-quarter.
  • 15 funds opened new Silence Therapeutics positions in Q4 2021 and 0 closed out, a net change of +15 holders.
  • The largest Silence Therapeutics buyer in Q4 2021 was Lombard Odier Asset Management (USA), an estimated $66.5M added.

Based on aggregated 13F filings for Q4 2021.